Katarzyna Morawska

5-FU therapeutic drug monitoring as a valuable option to reduce toxicity in patients with gastrointestinal cancer

Katarzyna Morawska, Françoise Goirand, Laurine Marceau et al. · Oncotarget · 2018 · 69 citations · Full text

Glutathione Metabolism, Mitochondria Activity, and Nitrosative Stress in Patients Treated for Mandible Fractures

Jan Borys, Mateusz Maciejczyk, Bożena Antonowicz et al. · Journal of Clinical Medicine · 2019 · 55 citations · Full text

Mandible Body, Glutathione Metabolism, Osteoporosis +18

Enhanced Salivary and General Oxidative Stress in Hashimoto’s Thyroiditis Women in Euthyreosis

Katarzyna Morawska, Mateusz Maciejczyk, Łukasz Popławski et al. · Journal of Clinical Medicine · 2020 · 37 citations · Full text

Healthy Subjects, Lipid Peroxidation, Immunology +20

Metabolism of prostaglandin F1α by the rat stomach

C.R. Pace-Asciak, Katarzyna Morawska, L. S. Wolfe · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 1970 · 29 citations

Gastrointestinal Pharmacology, Medicine, Physiology +5

Therapeutic drug monitoring as a tool to optimize 5-FU–based chemotherapy in gastrointestinal cancer patients older than 75 years

Pauline Macaire, Katarzyna Morawska, Julie Vincent et al. · European Journal of Cancer · 2019 · 23 citations · Full text

Therapeutic Drug Monitoring, Gastrointestinal Oncology, Medicine +9